1. Home
  2. BBUC vs AORT Comparison

BBUC vs AORT Comparison

Compare BBUC & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Business Corporation Exchangeable Subordinate Voting Shares

BBUC

Brookfield Business Corporation Exchangeable Subordinate Voting Shares

HOLD

Current Price

$34.36

Market Cap

2.5B

Sector

N/A

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$38.40

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBUC
AORT
Founded
2022
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
BBUC
AORT
Price
$34.36
$38.40
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$48.76
AVG Volume (30 Days)
65.0K
461.3K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
0.71%
N/A
EPS Growth
N/A
165.62
EPS
N/A
0.21
Revenue
N/A
$298,836,000.00
Revenue This Year
N/A
$13.95
Revenue Next Year
N/A
$11.16
P/E Ratio
N/A
$181.05
Revenue Growth
N/A
18.01
52 Week Low
$22.97
$21.97
52 Week High
$38.25
$48.25

Technical Indicators

Market Signals
Indicator
BBUC
AORT
Relative Strength Index (RSI) 43.34 45.22
Support Level $33.95 $30.24
Resistance Level $37.44 $44.29
Average True Range (ATR) 1.27 1.70
MACD -0.14 0.09
Stochastic Oscillator 13.75 63.64

Price Performance

Historical Comparison
BBUC
AORT

About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares

Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: